Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection

NCT00001386 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

NIH

Sponsor class

Conditions

Acquired Immunodeficiency Syndrome
HIV Infection

Interventions

DRUG: PCLUS 3-18 MN
DRUG: PCLUS 6.1 MN

Sponsor

National Cancer Institute (NCI)